FibroGen, Inc. (NASDAQ:FGEN) Q4 2024 Earnings Conference Call March 17, 2025 5:00 PM ET
Company Participants
Joanne Greller – LifeSci Advisors
Thane Wettig – CEO
David DeLucia – CFO
Conference Call Participants
Andy Sieh – William Blair
Matthew Keller – H.C. Wainwright
Operator
Hello everyone, and welcome to the FibroGen Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference, is being recorded.
Now, it’s my pleasure to turn the call over to, Joanne Greller. The floor is yours.
Joanne Greller
Thank you, operator. Good afternoon, everyone. Thank you for joining today, to discuss FibroGen’s fourth quarter and full year 2024 financial and business results. I’m Joanne Greller from LifeSci Advisors. Joining me on today’s call are Thane Wettig, our Chief Executive Officer and David DeLucia, our Chief Financial Officer. Following our prepared remarks, we will open the call to your questions.
I would like to remind you that remarks made on today’s call include forward-looking statements about FibroGen. Such statements may include, but are not limited to our collaborations with AstraZeneca and Astellas; financial guidance; the initiation, enrollment, design, conduct and results of clinical trials; our regulatory strategies and potential regulatory results; our research and development activities; commercial results and results of operations; risks related to our business; and certain other business matters.
Each forward-looking statement, is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. A more complete description of these and other material risks can be found in FibroGen’s filings with the SEC including our most recent Form 10-K and Form 10-Q.
FibroGen does not undertake any obligation
#FibroGen #FGEN #Earnings #Call #Transcript